Form 4 for STE Steris
Accepted 2025-06-06 00:00:00 ET · period of report 2025-06-04 · accession 0001628280-25-030023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-06 | 2025-06-05 | STE | Carestio Daniel A | Pres, CEO, Dir | S - Sale | $242.56 | -17.6K | 56.5K | -24% | -$4.28M |
| 2025-06-06 | 2025-06-04 | STE | Carestio Daniel A | Pres, CEO, Dir | F - Tax | $242.10 | -1,921 | 69.0K | -3% | -$465.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-06-05 | S | D | 7,520 | $241.85 | 61,491 | D | — | — | (F3) Price reflects a weighted average sale price for multiple transactions ranging from $241.33 to $242.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F2) As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. |
| 2 | Common | Ordinary Shares | 2025-06-05 | S | D | 5,126 | $243.49 | 51,385 | D | — | — | (F2) As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. |
| 3 | Common | Ordinary Shares | 2025-06-05 | S | D | 4,980 | $242.67 | 56,511 | D | — | — | (F4) Price reflects a weighted average sale price for multiple transactions ranging from $242.39 to $243.07 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F2) As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. |
| 4 | Common | Ordinary Shares | 2025-06-04 | F | D | 1,921 | $242.10 | 69,011 | D | — | — | (F1) 1,921 shares were withheld from the 4,283 restricted shares that vested on June 4, 2025. These 1,921 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,283 ordinary shares were awarded to Mr. Carestio on June 4, 2024. These vested shares were valued at the NYSE closing market price on June 4, 2025. (F2) As of June 4, 2025, 33,343 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2025; 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. |